| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |